ANGIOSCOPIC PREDICTION OF SUCCESSFUL DILATATION AND OF RESTENOSIS IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - SIGNIFICANCE OF YELLOW PLAQUE

被引:28
|
作者
ITOH, A
MIYAZAKI, S
NONOGI, H
DAIKOKU, S
HAZE, K
机构
[1] Division of Cardiology, National Cardiovascular Center, Suita, Osaka
[2] Division of Cardiology, National Cardiovascular Center, Suita, Osaka 565
[3] Department of Cardiology, Osaka City General Hospital, Miyakojimaku, Osaka, Osaka 534
关键词
CORONARY DISEASE; RESTENOSIS; ANGIOSCOPY; ANGIOPLASTY;
D O I
10.1161/01.CIR.91.5.1389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Coronary angiography has been used to assess the anatomy of coronary artery and intraluminal pathological changes. However, it has several limitations in its diagnostic quality and sensitivity in the detection of intraluminal details. Angioscopy has enabled coronary artery lumens to be visualized directly and fine intraluminal morphological changes to be detected. The information obtained by angioscopy is expected to provide new insights into the mechanisms and pathophysiology of transluminal coronary angioplasty. Methods and Results Forty-seven patients (39 men and 8 women) with stable angina were enrolled in the present study. Angioscopy was performed before and after angioplasty with a 0.68-mm angioscope with a double-guiding catheter system. The patients who were successfully evaluated by angioscopy were divided into two groups according to the color of the lesion: group 1, mainly yellow; and group 2, white. Angiographic, angioscopic, and clinical parameters in the two groups were compared. Detailed angioscopic findings were obtained in 36 of the 47 patients (77%) before percutaneous transluminal coronary angioplasty (PTCA) and in 24 of the 47 (51%) after PTCA. Yellow plaque were found in 13 of 36 (36%). Age, sex, presence of coronary risk factors, serum cholesterol level, and duration of angina showed no correlation with plaque color. The incidence rates of dissection and thrombi after angioplasty also were not different. Successful dilatation was achieved in 13 of 13 patients (100%) in group 1 and in 21 of 23 (91%) in group 2. The restenosis rate of group 1 was significantly lower than that in group 2 (16.7% versus 57.9%, P<.05). Cox proportional hazards model revealed that plaque color was the independent variable associated with restenosis after PTCA (P=.03). Conclusions The restenosis rate after successful balloon angioplasty differs, with the color of the target lesion being significantly higher in patients with solely white plaque. Therefore, angioscopic findings are highly predictive of restenosis.
引用
收藏
页码:1389 / 1396
页数:8
相关论文
共 50 条
  • [41] FACTORS AFFECTING THE RESTENOSIS RATE AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    BACH, R
    JUNG, F
    KOHSIEK, I
    OZBEK, C
    SPITZER, S
    SCHELLER, B
    DYCKMANS, J
    SCHIEFFER, H
    THROMBOSIS RESEARCH, 1994, 74 : S55 - S67
  • [42] EFFECT OF CILAZAPRIL ON VASCULAR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    YAMABE, T
    IMAZU, M
    YAMAMOTO, H
    UEDA, H
    HATTORI, Y
    HAYASHI, Y
    SEKIGUCHI, Y
    ITO, M
    YAMAKIDO, M
    CORONARY ARTERY DISEASE, 1995, 6 (07) : 573 - 579
  • [43] EVALUATION OF NEOPTERIN AS A MARKER FOR RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    EBER, B
    SCHUMACHER, M
    TATZBER, F
    KAUFMANN, P
    LUHA, O
    ESTERBAUER, H
    GASSER, R
    KLEIN, W
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (02) : 361 - 362
  • [44] LIPOPROTEIN(A) IS NOT A RISK FACTOR FOR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    SCHUMACHER, M
    TIRAN, A
    EBER, B
    TOPLAK, H
    WILDERSTRUSCHNIG, M
    KLEIN, W
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (05): : 572 - 572
  • [45] KETANSERIN PREVENTS EARLY RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    KLEIN, W
    EBER, B
    DUSLEAG, J
    ROTMAN, B
    KOLTRINGER, P
    LUHA, O
    VANHOUTTE, PM
    CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, 1990, 8 : 101 - 107
  • [46] Pulse pressure as a predictor of restenosis after percutaneous transluminal coronary angioplasty
    Bryniarski, L
    Jankowski, P
    Czarnecka, D
    Zabojszcz, M
    Kawecka-Jaszcz, K
    JOURNAL OF HYPERTENSION, 2002, 20 : S158 - S158
  • [47] Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty
    Salvioni, A
    Galli, S
    Marenzi, G
    Lauri, G
    Perego, GB
    Assanelli, E
    Guazzi, MD
    AMERICAN HEART JOURNAL, 1998, 135 (03) : 503 - 509
  • [48] Genetic predictive factors for restenosis after percutaneous transluminal coronary angioplasty
    Monraats, PS
    Agema, WRP
    Zwinderman, AH
    de Winter, RJ
    Tio, RA
    Doevendans, PAFM
    Crijns, HJGM
    de Maat, MPM
    Atsma, DE
    van der Laarse, A
    van der Wall, EE
    Jukema, JW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 53A - 53A
  • [49] PREDICTIVE FACTORS OF RESTENOSIS AFTER MULTIVESSEL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    LEFEUVRE, C
    BONAN, R
    LESPERANCE, J
    GOSSELIN, G
    JOYAL, M
    CREPEAU, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (12): : 840 - 844
  • [50] Metoprolol treatment to prevent restenosis following percutaneous transluminal coronary angioplasty
    Franzen, D
    Seifert, N
    Metha, A
    Höpp, HW
    CARDIOLOGY, 2002, 97 (02) : 94 - 98